These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 22267161)

  • 21. Early continuous inhibition of group 1 mGlu signaling partially rescues dendritic spine abnormalities in the Fmr1 knockout mouse model for fragile X syndrome.
    Su T; Fan HX; Jiang T; Sun WW; Den WY; Gao MM; Chen SQ; Zhao QH; Yi YH
    Psychopharmacology (Berl); 2011 May; 215(2):291-300. PubMed ID: 21181121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Negative Allosteric Modulation of mGluR5 Partially Corrects Pathophysiology in a Mouse Model of Rett Syndrome.
    Tao J; Wu H; Coronado AA; de Laittre E; Osterweil EK; Zhang Y; Bear MF
    J Neurosci; 2016 Nov; 36(47):11946-11958. PubMed ID: 27881780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired activity-dependent FMRP translation and enhanced mGluR-dependent LTD in Fragile X premutation mice.
    Iliff AJ; Renoux AJ; Krans A; Usdin K; Sutton MA; Todd PK
    Hum Mol Genet; 2013 Mar; 22(6):1180-92. PubMed ID: 23250915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome.
    Maurin T; Melancia F; Jarjat M; Castro L; Costa L; Delhaye S; Khayachi A; Castagnola S; Mota E; Di Giorgio A; Servadio M; Drozd M; Poupon G; Schiavi S; Sardone L; Azoulay S; Ciranna L; Martin S; Vincent P; Trezza V; Bardoni B
    Cereb Cortex; 2019 Jul; 29(8):3241-3252. PubMed ID: 30137253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered neuroligin expression is involved in social deficits in a mouse model of the fragile X syndrome.
    Dahlhaus R; El-Husseini A
    Behav Brain Res; 2010 Mar; 208(1):96-105. PubMed ID: 19932134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors.
    Nakamoto M; Nalavadi V; Epstein MP; Narayanan U; Bassell GJ; Warren ST
    Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15537-42. PubMed ID: 17881561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
    Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY
    Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of 5-HT7 serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and Fmr1 knockout mice, a model of Fragile X syndrome.
    Costa L; Spatuzza M; D'Antoni S; Bonaccorso CM; Trovato C; Musumeci SA; Leopoldo M; Lacivita E; Catania MV; Ciranna L
    Biol Psychiatry; 2012 Dec; 72(11):924-33. PubMed ID: 22817866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabotropic glutamate receptor 5/Homer interactions underlie stress effects on fear.
    Tronson NC; Guzman YF; Guedea AL; Huh KH; Gao C; Schwarz MK; Radulovic J
    Biol Psychiatry; 2010 Dec; 68(11):1007-15. PubMed ID: 21075228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.
    Zhang L; Alger BE
    J Neurosci; 2010 Apr; 30(16):5724-9. PubMed ID: 20410124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Group I metabotropic glutamate receptor antagonists alter select behaviors in a mouse model for fragile X syndrome.
    Thomas AM; Bui N; Perkins JR; Yuva-Paylor LA; Paylor R
    Psychopharmacology (Berl); 2012 Jan; 219(1):47-58. PubMed ID: 21656124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correction of fragile X syndrome in mice.
    Dölen G; Osterweil E; Rao BS; Smith GB; Auerbach BD; Chattarji S; Bear MF
    Neuron; 2007 Dec; 56(6):955-62. PubMed ID: 18093519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful cognitive aging in rats: a role for mGluR5 glutamate receptors, homer 1 proteins and downstream signaling pathways.
    Ménard C; Quirion R
    PLoS One; 2012; 7(1):e28666. PubMed ID: 22238580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of GluN2A NMDA receptors ameliorates synaptic plasticity deficits in the Fmr1
    Lundbye CJ; Toft AKH; Banke TG
    J Physiol; 2018 Oct; 596(20):5017-5031. PubMed ID: 30132892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-Type-Specific Translation Profiling Reveals a Novel Strategy for Treating Fragile X Syndrome.
    Thomson SR; Seo SS; Barnes SA; Louros SR; Muscas M; Dando O; Kirby C; Wyllie DJA; Hardingham GE; Kind PC; Osterweil EK
    Neuron; 2017 Aug; 95(3):550-563.e5. PubMed ID: 28772121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. β-Arrestin2 Couples Metabotropic Glutamate Receptor 5 to Neuronal Protein Synthesis and Is a Potential Target to Treat Fragile X.
    Stoppel LJ; Auerbach BD; Senter RK; Preza AR; Lefkowitz RJ; Bear MF
    Cell Rep; 2017 Mar; 18(12):2807-2814. PubMed ID: 28329674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of metabotropic glutamate receptor-dependent long-term depression via downregulation of mGluR5 after status epilepticus.
    Kirschstein T; Bauer M; Müller L; Rüschenschmidt C; Reitze M; Becker AJ; Schoch S; Beck H
    J Neurosci; 2007 Jul; 27(29):7696-704. PubMed ID: 17634364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development.
    Pop AS; Gomez-Mancilla B; Neri G; Willemsen R; Gasparini F
    Psychopharmacology (Berl); 2014 Mar; 231(6):1217-26. PubMed ID: 24232444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ribosome profiling in mouse hippocampus: plasticity-induced regulation and bidirectional control by TSC2 and FMRP.
    Hien A; Molinaro G; Liu B; Huber KM; Richter JD
    Mol Autism; 2020 Oct; 11(1):78. PubMed ID: 33054857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered neocortical rhythmic activity states in Fmr1 KO mice are due to enhanced mGluR5 signaling and involve changes in excitatory circuitry.
    Hays SA; Huber KM; Gibson JR
    J Neurosci; 2011 Oct; 31(40):14223-34. PubMed ID: 21976507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.